The Ad-CMV-Cre-mediated inactivation of Pten and the activation of KrasG12D in OSE cells, or the inactivation of both Pten and Apc, led to the development of endometrioid ovarian cancers [25,26]. This evidence concerns the gene PTEN and ovarian endometrioid adenocarcinoma.